Earnings Deep Dive: Tamron (7740) Q2 FY2026 Results and Analysis of Long-Term Vision and New Mid-Term Management Plan

This report provides a detailed analysis of the Q2 FY2026 financial results for Tamron Co., Ltd. (Ticker: 7740), based on the company's earnings presentation materials. It covers performance highlights, segment-specific trends, and the core pillars of the newly announced Long-Term Vision and the upcoming mid-term management plan, "Value Up29."

---

1. Long-Term Vision and the "Value Up29" Mid-Term Management Plan

Tamron is transforming from a traditional lens manufacturer into a "Comprehensive Optical and Sensing Solution Company," significantly revising its long-term vision and financial targets.

Revision of Quantitative Targets for the Long-Term Vision

As shown in the slide above, the company has unveiled its long-term vision for 2035: "Capturing, Measuring, and Connecting. Creating a company that fosters the health of people and nature." Quantitative targets have been substantially upgraded. Compared to the previous goals of "100 billion yen in sales and 10 billion yen in new business sales," the new targets are set at "over 200 billion yen in sales (including over 20 billion yen from new businesses)" and "sustainable ROE of 20% or higher."

As the second step toward achieving this vision, the company has positioned the next mid-term management plan, "Value Up29," covering the three-year period from 2027 to 2029. During this period, Tamron plans to establish a new business portfolio by leveraging both organic growth and inorganic growth (M&A, etc.).

Key Quantitative Targets and Financial Strategy for "Value Up29"

Specific numerical targets and financial strategies for 2029 are as follows:

• Sales : Over 120 billion yen (2029)
• Operating Profit : Over 25 billion yen (2029)
• ROE : Sustainably 20% or higher
• Equity Ratio : Optimized from 81% in FY2025 to approximately 75%
• Dividend Policy : From 2027 onwards, determined by the higher of a 60% payout ratio or 8% DOE (effectively 12% or higher DOE upon achieving 20% ROE)
• Additional Returns : Planned additional returns of approximately 18 billion yen (share buybacks, dividends, etc.) by the end of the next mid-term plan
• Capital Allocation : A total of 71 billion yen for growth investment (1.2x higher than the current plan), funded by 89 billion yen in operating cash flow (pre-R&D) and 31 billion yen in cash/debt, allocated to 30 billion yen for R&D, 20 billion yen for CAPEX, and 21 billion yen for strategic investments (M&A).

Business Portfolio Transformation Strategy

Regarding business structure, the company positions its highly profitable Photo-related business as a stable cash cow (CAGR of 5% or more), while aggressively expanding Industrial-related businesses (Surveillance & FA, Mobility & Healthcare, etc.) as new pillars of growth (CAGR of 15% or more). As indicated by the sales composition shift in the slide above, the portfolio will diversify from 71% Photo-related in 2025 to the 60% range in 2029, and 50% by 2035 (with Industrial-related businesses accounting for the other 50%).

---

2. Analysis of Q2 (First Half) FY2026 Results

In the first half of FY2026, despite a decline in Photo OEM products, strong performance in Industrial-related businesses (Surveillance & FA, Mobility & Healthcare) supported the company, resulting in year-on-year sales growth.

H1 Consolidated Earnings Summary

• Sales : 43,281 million yen (+3.8% YoY, +4.5% vs. plan)
• Gross Profit : 18,130 million yen (-4.2% YoY)
• Operating Profit : 7,689 million yen (-16.5% YoY, -0.1% vs. plan)
• Ordinary Profit : 7,741 million yen (-16.5% YoY, +0.5% vs. plan)
• Net Profit Attributable to Owners of Parent : 6,197 million yen (-9.9% YoY, +8.7% vs. plan)

Factors Affecting Operating Profit

The decrease in operating profit by 1,514 million yen (from 9,203 million yen in the previous year) is attributed to:

1. FX Impact (Positive) : +1,030 million yen due to the weaker yen against the dollar and euro.
2. Gross Profit Decline due to Product Mix (Negative) : -1,560 million yen due to lower sales in the high-margin Photo-related business and changes in product composition.
3. Gross Profit Decline due to Lower Sales (Negative) : -410 million yen from specific product sales declines.
4. Increase in SG&A and R&D Expenses (Negative) : -380 million yen total (R&D reinforcement: -170 million yen; personnel costs: -210 million yen).
5. US Tariff Impact (Negative) : -190 million yen .

---

3. Segment Performance Details

(1) Photo-related Business

• Sales : 27,534 million yen (-8.2% YoY, -3.0% vs. plan)
• Operating Profit : 5,943 million yen (-29.3% YoY, -18.6% vs. plan)
• Operating Margin : 21.6% (Previous year: 28.0%)

Trends and Factors : While own-brand lenses saw a significant decline in China (-43% YoY) due to inventory adjustments, growth in Europe (+23%), North America (+64%), and Japan (+6%) helped own-brand sales reach 17.1 billion yen (+4.2% YoY). However, the continued sluggishness in certain OEM orders since the second half of last year (10.4 billion yen, -23.2% YoY) led to an overall decline in segment revenue and profit.

(2) Surveillance & FA Business

• Sales : 7,711 million yen (+29.0% YoY, +20.5% vs. plan)
• Operating Profit : 1,026 million yen (+10.5% YoY, +46.7% vs. plan)
• Operating Margin : 13.3% (Previous year: 15.5%)

Trends and Factors : Surveillance lenses performed well (+33.6% YoY) due to demand for high-definition imaging in developed markets. FA lenses also saw a 1.4x increase in sales (+39.0% YoY) as customer inventory adjustments concluded. Camera modules achieved double-digit growth, significantly exceeding the segment plan.

(3) Mobility & Healthcare and Other Businesses

• Sales : 8,035 million yen (+39.6% YoY, +21.7% vs. plan)
• Operating Profit : 1,987 million yen (+48.0% YoY, +65.6% vs. plan)
• Operating Margin : 24.7% (Previous year: 23.3%)

Trends and Factors : Automotive sales reached 6.5 billion yen (+34.1% YoY) due to the expansion of ADAS. Medical product sales surged to 900 million yen (+113.5% YoY), more than doubling, as the expanded lineup for minimally invasive surgery contributed significantly to profit margins.

---

4. Full-Year FY2026 Forecast and Shareholder Return Policy Revision

Based on H1 results and recent order trends, the company has revised its full-year consolidated earnings forecast.

Revisions to Full-Year Forecast

Reflecting the strong performance in automotive and medical sectors, sales have been revised upward .

• Sales : 93,000 million yen (+2,000 million yen from initial plan, +9.3% YoY)
• Operating Profit : 18,500 million yen (unchanged, +11.2% YoY)
• Operating Margin : 19.9%
• Ordinary Profit : 18,500 million yen (unchanged, +10.8% YoY)
• Net Profit : 13,690 million yen (unchanged, +16.4% YoY)
• Assumed FX Rates : 1 USD = 159.16 JPY, 1 EUR = 182.31 JPY

Segment Outlook

• Photo-related : Sales 63 billion yen (as planned), Operating Profit 16.1 billion yen (-1.1 billion yen downward revision due to raw material costs and R&D). Recovery expected in H2 with over 10 new own-brand product launches.
• Surveillance & FA : Sales 14.5 billion yen, Operating Profit 1.9 billion yen (as planned).
• Mobility & Healthcare : Sales 15.5 billion yen (+2.0 billion yen upward revision), Operating Profit 3.5 billion yen (+1.0 billion yen upward revision).

Changes to Shareholder Return Policy and Dividend Increase

• FY2026 Dividend Increase : Annual dividend forecast raised from 37 yen to 51 yen per share (equivalent to a 60% payout ratio).
• New Return Policy (from 2027) : Commitment to the higher of a 60% payout ratio or 8% DOE .
• Additional Returns : Planned 18 billion yen in additional returns (share buybacks) to optimize the equity ratio to approximately 75% by 2029.

---

Summary

Tamron's Q2 FY2026 results demonstrate a structural shift: despite headwinds in the Photo-related OEM business and the Chinese market, industrial sectors like Mobility & Healthcare and Surveillance & FA are driving overall sales growth. Furthermore, the new Long-Term Vision (200 billion yen sales, 20% ROE) and the "Value Up29" plan clarify the company's evolution into a comprehensive optical and sensing solution provider, supported by a proactive shareholder return policy centered on a 60% payout ratio.